CLINICAL_TRIALS trial_result · 2014-02-13

Clinical Trial Update: A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 [Phase 2]

Anthera Pharmaceuticals completed the Phase 2 AN-SLE3321 trial in subjects with systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Anthera Pharmaceuticals | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED